Elutia (ELUT) Cash from Investing Activities (2019 - 2026)
Elutia's (ELUT) quarterly Cash from Investing Activities came in at -$91000.0 in Q2 2026, up 20.18% year-over-year from -$75722.6 in Q2 2025, and down 167.65% quarter-over-quarter from -$34000.0 in Q1 2026.
Powered by 
Analysis
Elutia (ELUT) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Elutia has disclosed Cash from Investing Activities across 8 years of filings, most recently posting -$91000.0 for Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 20.18% year-over-year to -$91000.0; the TTM figure through Jun 2026 stood at $78.8 million (up 7730.78% YoY), while the FY2025 annual figure was $78.6 million, up 16673.63% from the prior year.
- Cash from Investing Activities came in at -$91000.0 for Q2 2026 at Elutia, down from -$34000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $79.6 million in Q4 2025 to a low of -$630000.0 in Q3 2025.
- Average Cash from Investing Activities over 5 years is $5.1 million, with a median of -$92500.0 recorded in 2024.
- The largest YoY upside for Cash from Investing Activities was 84760.64% in 2025 against a maximum downside of 1753.33% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$134000.0 in 2022, then soared by 10948.51% to $14.5 million in 2023, then slumped by 100.65% to -$94000.0 in 2024, then soared by 84760.64% to $79.6 million in 2025, then sank by 100.11% to -$91000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$91000.0 in Q2 2026, -$34000.0 in Q1 2026, and $79.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Elutia | 35.28 Mn | 15.39 Mn | 1.45 Mn | -91,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -91,000.00 |
| Mar 31, 2026 | -34,000.00 |
| Dec 31, 2025 | 79.58 Mn |
| Sep 30, 2025 | -630,000.00 |
| Jun 30, 2025 | -114,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Sep 30, 2024 | -547,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Dec 31, 2023 | 14.54 Mn |
| Sep 30, 2023 | -62,000.00 |
| Jun 30, 2023 | -85,000.00 |
| Mar 31, 2023 | -182,000.00 |
| Dec 31, 2022 | -134,000.00 |
| Sep 30, 2022 | -117,000.00 |
| Jun 30, 2022 | -255,000.00 |
| Mar 31, 2022 | -34,000.00 |
| Dec 31, 2021 | -25,000.00 |
| Sep 30, 2021 | -97,000.00 |